The US Food and Drug Administration (FDA) announced today its support towards reducing the manufacture of products that use/contain bisphenol-A (BPA) such as in baby bottles, infant feeding cups and food can linings while the agency continues to dither whether or not to ban these products.
The FDA said studies employing standardized toxicity tests still continues to affirm the safety of current low levels of human exposure to BPA. But pressures from the media, consumer advocates, and study-after-study announcing the possible harmful effects of BPA, even at very low levels, forces the FDA to reconsider its stand.
The agency said it will pursue additional studies to address the uncertainties in various BPA-related findings, as well as seek public input and input from other expert agencies. The FDA also announced that it will support a shift to a more robust regulatory framework for oversight of BPA, if necessary, to be able to respond quickly to protect the public.
The FDA’s National Center for Toxicological Research is pursuing a set of studies on the safety of low doses of BPA, including assessment of the novel endpoints where concerns have been raised. These include studies pursued in collaboration with the National Toxicology Program and with support and input from the National Institute for Environmental Health Sciences. Depending on the results, each could influence regulatory decisions about BPA.
So the FDA’s possible ban is still up in the air as it continues its quest to find the truth about BPA. Meanwhile, the chemical industry remains steadfast on their defense in the safety of current BPA levels found in baby bottles, sippy cups and metal linings of canned foods.
The American Chemistry Council (ACC) released a statement saying that they were disappointed by the FDA’s recommendations, which are likely to further confuse and worry consumers about BPA.
ACC did emphasize that the FDA continues to confirm that exposure to BPA in food contact products has not been proven harmful to children or adults.